EMEA-000410-PIP01-08-M04

Key facts

Invented name
Rapiscan
Active substance
regadenoson
Therapeutic area
Cardiovascular diseases
Decision number
P/0030/2019
PIP number
EMEA-000410-PIP01-08-M04
Pharmaceutical form(s)
Solution for injection
Condition(s) / indication(s)
Diagnosis of myocardial perfusion disturbances
Route(s) of administration
Intravenous use
Contact for public enquiries
GE Healthcare AS

Tel.  +44 1494 543259
E-mail: vincenzo.cannizzaro@ge.com

Decision type
PM: decision on the application for modification of an agreed PIP

Decision

How useful was this page?

Add your rating